Clinical Trial Update: Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of ritlecitinib with nbUVB versus ritlecitinib alone for vitiligo, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Ritlecitinib (ritlecitinib)
• nbUVB phototherapy (narrowband ultraviolet B phototherapy)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Vitiligo | Phase 2 | Status: NOT_YET_RECRUITING